Neurovascular Intervention Devices Market, 2024 - Market Set to Reach $4.47 Billion
DUBLIN, May 24, 2018 /PRNewswire/ --
The "Neurovascular Intervention Devices Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The Neurovascular Intervention devices global market is expected to grow at a high single digit CAGR to reach $4,473.2 million by 2024
The increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in aging population, technological advancement, acquisitions and favourable reimbursements are increasing the use of artificial embolization devices, stents, thromobectomy devices and support devices which include microcatheters, embolic protection system and others as an efficient way for treating the neurovascular diseases.
Neurovascular Intervention devices global market is segmented on the basis of products, applications and geography. The products are segmented into artificial embolization devices, stents, thrombectomy devices and support devices. The artificial embolization devices segment accounted the largest share in 2017 and is projected to grow at mid single digit CAGR from 2017 to 2024 due to technological advancements in coils & flow diverter, development of coils for dual application i.e. for intracranial aneurysm and arteriovenous malformation.
Key Topics Covered:
1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Report Scope
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Increase In Incidence And Prevalence Of Neurovascular Diseases
3.3.1.2 Increase In Ageing Population
3.3.1.3 Technological Advancements In Minimally Invasive Products
3.3.1.4 Favorable Reimbursement Policies
3.3.1.5 Acquisitions
3.3.2 Restraints And Threats
3.3.2.1 Adverse Events And Complications With The Implantations Of Neurovascular Intervention Devices
3.3.2.2 Lack Of Skilled And Trained Professionals
3.3.2.3 Product Recalls
3.3.2.4 Stringent Regulatory Polices
3.3.2.5 Availability Of Alternative Products
3.4 Regulatory Affairs
3.5 Reimbursement Scenario
3.6 Clinical Trials
3.7 Patent Trends
3.8 Technological Advancements
3.8.1 Introduction
3.8.2 Integrated Balloon System
3.8.3 Soft Coil Technology
3.8.4 Adujstable Clot Retreiver
3.8.5 Advancements In Flow Diverter
3.9 Product Approvals
3.10 Porter's Five Force Analysis
3.11 Supply Chain Analysis
3.12 Market Share Analysis By Major Players
3.13 Neurovascular Intervention Devices Number Of Units By Region
3.14 Neurovascular Intervention Devices Company Comparison Table By Classification, Products And Applications
3.15 Market Penetration Of Neurovascular Intervention Device Market
4 Neurovascular Intervention Devices Global Market, By Product
4.1 Introduction
4.2 Artificial Embolization Devices
4.2.1 Coils
4.2.1.1 Bare Metal Coils
4.2.1.2 Coated Coils
4.2.2 Liquid Embolics
4.2.3 Flow Diverters
4.2.4 Flow Disruptor
4.3 Stents
4.3.1 Intracranial Stents
4.3.1.1 Stenosis Stents
4.3.1.2 Aneurysm Coil Stents
4.3.1.3 Neck Reconstruction Stents
4.3.1.4 Stent Graft
4.3.2 Carotid Stents
4.4 Thrombectomy Devices
4.4.1 Stent Retrievers
4.4.2 Aspiration Devices
4.5 Support Devices
4.5.1 Microcatheters
4.5.2 Embolic Protection System
4.5.3 Others
5 Neurovascular Intervention Devices Global Market, By Application
5.1 Introduction
5.2 Intracranial Aneurysm
5.3 Ischemic Stroke
5.4 Arteriovenous Malformation
5.5 Carotid Stenosis And Others
6 Regional Analysis
7 Competitive Landscape
7.1 Introduction
7.2 Agreement
7.3 Approvals
7.4 Acquisitions
7.5 New Product Launch
7.6 Other Developments
8 Major Companies
- Asahi Intecc Co., Ltd.
- Balt Extrusion
- Balton Sp. z o.o.
- Boston Scientific Corporation
- Cardiatis
- Cardinal Health Inc
- Contego Medical, LLC
- Evasc Medical Systems
- Inspire MD
- Johnson & Johnson
- Medtronic Plc
- Merlin MD Pte. Ltd.
- Microport Scientific Corporation
- NexGen Medical Systems, Inc
- Oxford Endovascular Ltd
- Penumbra Inc
- Perflow Medical Ltd
- Phenox GmbH
- Rapid Medical
- Silk Road Medical Inc
- Stryker Corporation
- Terumo Corporation
- W. L. Gore & Associates, Inc
For more information about this report visit https://www.researchandmarkets.com/research/jgmh2m/neurovascular?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article